Suppr超能文献

维甲酸和地塞米松对7-溴甲基苯并[a]蒽促进的小鼠皮肤肿瘤形成的抑制作用。

Inhibition of 7-bromomethylbenz[a]anthracene-promoted mouse skin tumor formation by retinoic acid and dexamethasone.

作者信息

Verma A K, Garcia C T, Ashendel C L, Boutwell R K

出版信息

Cancer Res. 1983 Jul;43(7):3045-9.

PMID:6406052
Abstract

Retinoic acid, a potent inhibitor of mouse skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate, fails to inhibit tumor formation by the complete carcinogen, 7, 12-dimethylbenz[a]anthracene (DMBA). To obtain further clues about the nature of the mechanism of the carcinogenic process as well as the mechanism of the effect of retinoic acid on tumor promotion, the effect of retinoic acid and two other modifiers (dexamethasone and 7,8-benzoflavone) of tumor formation on tumor promotion by 7-bromomethylbenz[a]anthracene (BrMBA) was determined. BrMBA, a structural analogue of DMBA, is a weak mouse skin tumor-initiating agent but is a good skin tumor promoter. Application of 10, 100, and 200 nmol of BrMBA twice weekly to DMBA-initiated skin resulted in 0, 1.6, and 2.5 papillomas per mouse, and 0, 44, and 60% of mice had papillomas at the 25th week of promotion treatment, respectively. Application of 17 nmol of retinoic acid or 76 nmol of dexamethasone 30 min prior to each twice weekly application of 100 nmol of BrMBA to DMBA-initiated skin inhibited the formation of skin papillomas by 73 and 100%, respectively. 7,8-Benzoflavone, at a 367-nmol dose, did not inhibit tumor promotion by BrMBA. Application of 200 nmol of BrMBA to mouse skin induced epidermal ornithine decarboxylase activity; a peak activity was observed between 8 and 18 hr following BrMBA treatment. Application of 17 nmol of retinoic acid or 76 nmol of dexamethasone inhibited the induction of ornithine decarboxylase activity by BrMBA. 7,8-Benzoflavone did not inhibit the induction of ornithine decarboxylase activity by BrMBA. Retinoic acid and dexamethasone, which inhibit tumor promotion by 12-O-tetradecanoylphorbol-13-acetate, also inhibited tumor promotion by BrMBA, but the nature of the mechanism of tumor promotion by BrMBA is unclear; BrMBA did not inhibit specific binding of 12-O-[3H]tetradecanoylphorbol-13-acetate to the cellular membrane fraction of mouse epidermis.

摘要

维甲酸是一种有效的由12 - O - 十四烷酰佛波醇 - 13 - 乙酸酯引发的小鼠皮肤肿瘤促进作用的抑制剂,但它不能抑制由完全致癌物7,12 - 二甲基苯并[a]蒽(DMBA)诱导的肿瘤形成。为了进一步了解致癌过程的机制本质以及维甲酸对肿瘤促进作用的影响机制,研究了维甲酸以及另外两种肿瘤形成调节剂(地塞米松和7,8 - 苯并黄酮)对7 - 溴甲基苯并[a]蒽(BrMBA)引发的肿瘤促进作用的影响。BrMBA是DMBA的结构类似物,是一种弱的小鼠皮肤肿瘤启动剂,但却是一种良好的皮肤肿瘤促进剂。每周两次向经DMBA启动的皮肤涂抹10、100和200 nmol的BrMBA,每只小鼠分别产生0、1.6和2.5个乳头状瘤,在促进治疗的第25周,分别有0、44和60%的小鼠出现乳头状瘤。在每周两次向经DMBA启动的皮肤涂抹100 nmol的BrMBA之前30分钟,涂抹17 nmol的维甲酸或76 nmol的地塞米松,分别使皮肤乳头状瘤的形成抑制了73%和100%。367 - nmol剂量的7,8 - 苯并黄酮不能抑制BrMBA的肿瘤促进作用。向小鼠皮肤涂抹200 nmol的BrMBA可诱导表皮鸟氨酸脱羧酶活性;在BrMBA处理后8至18小时观察到活性峰值。涂抹17 nmol的维甲酸或76 nmol的地塞米松可抑制BrMBA诱导的鸟氨酸脱羧酶活性。7,8 - 苯并黄酮不能抑制BrMBA诱导的鸟氨酸脱羧酶活性。抑制由12 - O - 十四烷酰佛波醇 - 13 - 乙酸酯引发的肿瘤促进作用的维甲酸和地塞米松,也抑制了BrMBA引发的肿瘤促进作用,但BrMBA引发肿瘤促进作用的机制本质尚不清楚;BrMBA不抑制12 - O - [3H]十四烷酰佛波醇 - 13 - 乙酸酯与小鼠表皮细胞膜部分的特异性结合。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验